Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07256652 · ClinicalTrials.gov registry record · NA
How Does YES Bar Affect Blood Glucose Levels?
A NA study of Blood Glucose Monitoring, sponsored by Efforia.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07256652 is a NA study of Blood Glucose Monitoring that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07256652, a NA study of Blood Glucose Monitoring, is actively recruiting participants, sponsored by Efforia.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Curious to see if there is a sweet treat that doesn't spike your blood sugar (avoiding the energy crash, inflammation, and weight gain)? This study uses the Abbott Lingo CGM to see how your blood glucose levels responds to YES Bar-an all natural, gluten-free, plant-based bar that tastes like dessert. You'll track your levels before and after eating it to see if it fits into your metabolic health. (iOS Only)
Conditions Studied
Interventions
- OTHER YES Bar
Study Locations (1)
New York
- Efforia - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-08-25 |
| Est. Completion | 2026-08-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07256652
The ClinicalTrials.gov registry entry for NCT07256652 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Efforia, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Blood Glucose Monitoring appearing as the primary indexed condition, and to 1 intervention - of which YES Bar is the first listed.
NCT07256652 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07256652 about?
NCT07256652 is a clinical study titled "How Does YES Bar Affect Blood Glucose Levels?". Curious to see if there is a sweet treat that doesn't spike your blood sugar (avoiding the energy crash, inflammation, and weight gain)? This study uses the Abbott Lingo CGM to see how your blood glucose levels responds to YES Bar-an all natural, gluten-free, plant-based bar that tastes like dessert...
What is the current status of trial NCT07256652?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-08-25. Estimated completion is 2026-08-25.
What conditions does trial NCT07256652 study?
This clinical trial studies the following conditions: Blood Glucose Monitoring.
What interventions are being tested in trial NCT07256652?
The interventions under investigation include: YES Bar (OTHER).
Who is sponsoring clinical trial NCT07256652?
This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07256652 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.